General Medicine Raises $120M Series B for Nationwide Healthcare Store

General Medicine announced $120M in Series B financing on October 6, 2026. General Medicine raised a $120 million Series B led by Andreessen Horowitz to expand its nationwide healthcare store into more categories of care.

Round details

The financing includes backing from Andreessen Horowitz, Matrix, VXI Capital, Eli Lilly and Company, Mercy Health (through Granger Management), BoxGroup. The company did not publish a valuation with the announcement.

Round: Series B
Capital announced: $120M
Total funding reported: $152M
Headquarters: San Francisco, CA

How the company plans to use the capital

General Medicine said it will use the new funding to expand its store into more categories of care. The announcement did not specify a more detailed use of proceeds.

Why this matters for GTM teams

The round brings General Medicine’s total funding to $152 million. Its store lists more than 2,900 products and services across medications, labs, telehealth, specialist e-consults and select in-person visits, and shows insurance and cash prices before customers decide.

Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.

Source and methodology

This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.

Primary source: General Medicine Series B announcement.